Evidence map›Paper›PMID 32948007›Full record

ArticleAntioxidants (Basel, Switzerland)2020

Combined Treatment with Low Cytotoxic Ethyl Acetate

Sheng-Yao Peng, Li-Ching Lin, Zhe-Wei Yang, Fang-Rong Chang, Yuan-Bin Cheng, Jen-Yang Tang, Hsueh-Wei Chang

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Journal of personalized medicine · 2021
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sheng-Yao PengDepartment of Biomedical Science and Environmental Biology, PhD Program in Life Sciences, College of Life Science, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Li-Ching LinDepartment of Radiation Oncology, Chi-Mei Foundation Medical Center, Tainan 71004, Taiwan.
Zhe-Wei YangDepartment of Biomedical Science and Environmental Biology, PhD Program in Life Sciences, College of Life Science, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Fang-Rong ChangGraduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.ORCID 0000-0003-2549-4193
Yuan-Bin ChengGraduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.ORCID 0000-0001-6581-1320
Jen-Yang TangDepartment of Radiation Oncology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.ORCID 0000-0002-5690-0708
Hsueh-Wei ChangDepartment of Biomedical Science and Environmental Biology, PhD Program in Life Sciences, College of Life Science, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.ORCID 0000-0003-0068-2366
Kaohsiung Medical University · TWChung Hwa University of Medical Technology · TW

Funding

Chimei-KMU jointed project 109CM-KMU-007Health and welfare surcharge of tobacco products, the Ministry of Health and Welfare, Taiwan, Republic of China MOHW109-TDU-B-212-134016Kaohsiung Medical University Hospital KMHU 108-8R67Kaohsiung Medical University Research Center KMU-TC108A04Ministry of Science and Technology, Taiwan MOST 108-2320-B-037-015-MY3, MOST 108-2314-B-037-020, MOST 108-2628-B-037-001National Sun Yat-sen University-KMU Joint Research Project #NSYSUKMU 109-I002
6 · The paper itself

Abstract

Ultraviolet-C (UVC) irradiation provides an alternative radiotherapy to X-ray. UVC sensitizer from natural products may improve radiotherapy at low cytotoxic side effects. The aim of this study is to assess the regulation for oral cancer cell proliferation by a combined treatment of UVC and our previously reported anti-oral cancer natural product (ethyl acetate extract of

Indexed as

DNA damageNepenthesoral cancerROSUVC sensitizer

Identifiers

PMID32948007
PMCPMC7555961
OpenAlexW3084614532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.